Suzanne Louise Bruhn's Net Worth

$1.19 Million

Estimate Recalculated Jul 16, 2024 03:25PM EST

Who is Suzanne Louise Bruhn?

Suzanne Louise Bruhn has an estimated net worth of $1.19 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., PLIANT THERAPEUTICS, INC., Aeglea BioTherapeutics, Inc., NOVELION THERAPEUTICS INC., Avalo Therapeutics, Inc., Mind Medicine (MindMed) Inc., Vigil Neuroscience, Inc., and Raptor Pharmaceutical Corp.

SEC CIK

Suzanne Louise Bruhn's CIK is 0001517790

Past Insider Trading and Trends

2020 was Suzanne Louise Bruhn's most active year for acquiring shares with 8 total transactions. Suzanne Louise Bruhn's most active month to acquire stocks was the month of May. 2013 was Suzanne Louise Bruhn's most active year for disposing of shares, totalling 9 transactions. Suzanne Louise Bruhn's most active month to dispose stocks was the month of August. 2015 saw Suzanne Louise Bruhn paying a total of $326,700.00 for 122,023 shares, this is the most they've acquired in one year. In 2016 Suzanne Louise Bruhn cashed out on 177,447 shares for a total of $510,903.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Travere Therapeutics, Inc. (TVTX) Snapshot price: $8.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.27%
6.5K
—
—
22.25K
May 8
Form 4
+40.00%
4.5K
—
—
15.75K
May 17
Form 4
+36.36%
3K
—
—
11.25K
May 11
Form 4
+57.14%
3K
—
—
8.25K
May 14
Form 4
∞
5.25K
—
—
5.25K
Apr 8
Form 3
—
0
—
—
0
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 29
Form 3
—
0
—
—
0
No matching records found

Aeglea BioTherapeutics, Inc. (AGLE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Feb 15
Form 3
—
0
—
—
0
No matching records found

NOVELION THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 9
Form 4
—
0
—
—
0
Oct 2
Form 3
—
0
—
—
0
No matching records found

Avalo Therapeutics, Inc. (AVTX) Snapshot price: $4.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Apr 24
Form 3
—
0
—
—
0
No matching records found